cremona Italian scientist investigated after animal cloning experiment

The Lancet ◽  
1999 ◽  
Vol 354 (9187) ◽  
pp. 1365 ◽  
Author(s):  
Bruno Simini
2007 ◽  
Vol 25 (1) ◽  
pp. 39-43 ◽  
Author(s):  
Larisa Rudenko ◽  
John C Matheson ◽  
Stephen F Sundlof

1998 ◽  
Vol 67 (4) ◽  
pp. 423-430
Author(s):  

AbstractObjective: Review of animal cloning legislation (legal restrictions) and its potential impact on the competitiveness of the European biotech industry.Material and methods: Review and comparison of enacted and pending international legislation on animal cloning techniques (US and EU), analyzing materials obtained by database searches and direct contact with EU and US officials. Market prices on therapeutic hormones were provided by Apoteksbolaget, Sweden. The estimations for the production capacity of transgenic animals are based on information from Genzyme USA, and include results obtained from a review of international articles on animal cloning.Results: Recent scientific and technological progress in modern cloning techniques holds promise to be able to produce an increased amount of cheaper human therapeutics (growth hormone, factor IX, etc.) in the near future. Animal cloning restrictions, as recently introduced in Holland, could thus, if spread to other EU Member States, have a stigmatizing effect upon these developments. This, of course, would have serious implications for the competitiveness of the European biotech industry, reducing the expected employment potential in this field. The European situation can be usefully compared with the developments in the US, where no animal cloning restriction is foreseen in the currently debated US cloning legislation, which refers exclusively to human cloning restrictions. A relocation of the European biotech industry to the US has already been reported on, a process that would, if continued, subsequently diminish the European potential for influencing future developments in the area.


10.1038/89834 ◽  
2001 ◽  
Vol 7 (7) ◽  
pp. 753-753 ◽  
Author(s):  
Cesare Galli ◽  
Giovanna Lazzari
Keyword(s):  

2004 ◽  
Vol 16 (2) ◽  
pp. 145
Author(s):  
H.R. Kim ◽  
J.K. Kang ◽  
J.T. Yoon ◽  
H.H. Seong ◽  
C.S. Park ◽  
...  

Practical application of animal cloning by somatic cell nuclear transfer (SCNT) has been hampered by extremely low success rate. Most clones die before birth and survivors frequently display abnormalities. It is speculated that epigenetic reprogramming is somehow defective in reconstituted embryos (Reik W et al., 2003 Theriogenology 59 21–32; Han YM et al., 2003 Theriogenology 59, 33–44). It is likely that placental anomalies are directly or indirectly responsible for the death of cloned fetus and neonates. To address this question, we analyzed protein patterns of two placentae obtained after postnatal death of fetuses from SCNT of Korean Native Cattle and two normal placentae obtained after birth of AI fetuses. Global proteomics approach was employed by using 2-D gel electrophoresis and mass spectrometry to separate the different placenta proteins. Proteins within an isoelectric point range of 4.0 to 7.0 and a molecular weight range of 20–100kDa were analyzed by means of 2-D gel electrophoresis with three replications of each sample. The stained gels were scanned and calibrated at an optical resolution of 63.5μm/pixel using a GS-710 (Bio-Rad Laboratories, Hercules, CA, USA). Approximately 480 spots were detected in placental 2-D gel stained with coomassie-blue. Then, image analysis by Malanie III (Swiss Institute for Bioinformatics, Geneva, Switzerland) was performed to detect variations in protein spots between normal and SCNT placentae. In the comparison of normal and SCNT samples, at least 15 protein spots were identified as regulated differentially. Using MALDI-TOF-MS (PerSeptive Biosystems, Framinham, MA, USA), 10 spots were identified as up-regulated proteins in SCNT placentae including BPLP-I, Rho GDI 2, osteoclast stimulating factors, SM22, 60S Acidic Ribosomal and Protein P2, whereas five spots were down-regulated proteins such as Peroxiredoxin 2. Mass spectrometry with sequencing was used to further analyze the uncharacterized proteins. Most identified proteins in this analysis appeared to be related to cell proliferation and differentiation, fetal growth and development or metabolism. Further, specific functions of proteins in placenta have been investigated at the molecular levels during pregnancy.


1991 ◽  
Vol 68 (8) ◽  
pp. 707
Author(s):  
Shawn O. Farrell ◽  
Lynn E. Farrell ◽  
Lori K. Dircks

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Liqin Wang ◽  
Jiapeng Lin ◽  
Juncheng Huang ◽  
Jing Wang ◽  
Yuncheng Zhao ◽  
...  

Sheep oocytes derived from the ovaries collected from the slaughterhouse are often used for research onin vitroembryo production, animal cloning, transgenesis, embryonic stem cells, and other embryo biotechnology aspects. Improving thein vitroculture efficiency of oocytes can provide more materials for similar studies. Generally, determination of oocyte quality is mostly based on the layers of cumulus cells and cytoplasm or cytoplasm uniformity and colors. This requires considerable experience to better identify oocyte quality because of the intense subjectivity involved (Gordon (2003), Madison et al. (1992) and De Loos et al. (1992)). BCB staining is a function of glucose-6-phosphate dehydrogenase (G6PD) activity, an enzyme synthesized in developing oocytes, which decreases in activity with maturation. Therefore, unstained oocytes (BCB−) are high in G6PD activity, while the less mature oocytes stains are deep blue (BCB+) due to insuffcient G6PD activity to decolorize the BCB dye.


Sign in / Sign up

Export Citation Format

Share Document